Bastion Therapeutics is a preclinical stage biotechnology startup that uses proprietary platform technology to boost Them for immune system.
Bastion Therapeutics has raised $840K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2023.
Bastion Therapeutics's investors include Pioneer Group, Wren Capital, NG Bio.
Bastion Therapeutics is headquartered in London, United Kingdom.
Bastion Therapeutics is a preclinical stage biotechnology startup that uses proprietary platform technology to boost Them for immune system.
Bastion Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Bastion Therapeutics — Funding & Investors." VCBacked, September 12, 2023, https://www.vcbacked.co/company/bastion-therapeutics. Accessed August 16, 2026.
VCBacked. (2023). Bastion Therapeutics — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/bastion-therapeutics
{{cite web |title=Bastion Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/bastion-therapeutics |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated